| Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
|---|
| 05/12/2009 | US7531657 Reacting compounds such as S)-3-benzyloxycarbonylamino-2-piperidone with a sililating agent, subsequently reacting it with a phosphorus oxyhalide , reacting with ammonia to produce compounds such as S)-3-benzyloxycarbonylamino-1-diaminophosphinyl-2-piperidone |
| 05/12/2009 | US7531573 Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory disease |
| 05/12/2009 | US7531556 Compositions useful as inhibitors of rock and other protein kinases |
| 05/12/2009 | CA2348890C Use of staurosporine derivatives for treating ocular neovascular diseases |
| 05/12/2009 | CA2253997C Phosphonic acid-substituted benzazepinone-n-acetic acid derivatives, processes for their preparation and pharmaceutical compositions comprising them |
| 05/07/2009 | WO2009059237A2 Novel bismuth precursors for cvd/ald of thin films |
| 05/07/2009 | WO2009058572A1 Organophosphonate oligomers |
| 05/07/2009 | WO2009057609A1 Sugar alcohol anhydride composition having good storage stability, and process for production of polycarbonate using the same |
| 05/07/2009 | WO2009056955A1 Amine-bearing phospholipids (abps), their synthesis and use |
| 05/07/2009 | WO2009056952A1 Geminal bisphosphonates, their preparation and their use in the field of oncology |
| 05/07/2009 | WO2009056693A1 Novel derivatives of n, n'- 2, 4-dianilinopyrimidines, preparation thereof as medicaments pharmaceutical compositions and in particular as ikk inhibitors |
| 05/07/2009 | WO2009055993A1 Substituted phosphazene compounds and their use as flame resistance additives for organic polymers |
| 05/07/2009 | WO2009055912A1 Cationic transition metal catalysts |
| 05/07/2009 | WO2009016235A3 Chelating agent based ionic liquids, a process to prepare them, and their use |
| 05/07/2009 | WO2006127620A3 Compositions containing pufa and methods of use thereof |
| 05/07/2009 | US20090118508 Novel phosphonic acid compounds as inhibitors of serine proteases |
| 05/07/2009 | US20090118504 Novel phosphonic acid compounds as inhibitors of serine proteases |
| 05/07/2009 | US20090118239 Amorphous and crystalline forms of ibandronate disodium |
| 05/07/2009 | US20090118238 Deuterium-enriched alendronate |
| 05/07/2009 | US20090118236 such as 2-[(3,5-dimethyl-4-(4'-hydroxy-3'-iso-propylbenzyl) phenoxy)methyl]-4-(3-chlorophenyl)-2-oxo-2 lambda 5-[1,3,2]-dioxaphosphonane, used for preventing and/or treating metabolic disorders such as obesity, hypercholesterolemia and hyperlipidemia |
| 05/07/2009 | US20090118235 Novel phosphonic acid compounds as inhibitors of serine proteases |
| 05/07/2009 | US20090118234 Novel phosphonic acid compounds as inhibitors of serine proteases |
| 05/07/2009 | DE102007052640A1 Verfahren zur Hydroformylierung A process for the hydroformylation |
| 05/07/2009 | CA2703671A1 Cationic transition metal catalysts |
| 05/07/2009 | CA2702801A1 Organophosphonate oligomers |
| 05/07/2009 | CA2643394A1 Ligands, their preparation and uses thereof in asymmetric reactions |
| 05/06/2009 | EP2055695A1 Composition for alkylation, and method for detoxification of toxic compound using the composition |
| 05/06/2009 | EP2054424A1 Vinyl phosphonate lysophosphatidic acid receptor antagonists |
| 05/06/2009 | EP2054423A1 Alpha-amino acid phosphonic acid compounds, method of preparation and use thereof |
| 05/06/2009 | EP1732938B1 Organophosphorous indazole derivatives and use thereof as protein kinase inhibitors |
| 05/06/2009 | CN101426801A Low triphenylphosphate, high phosphorous content isopropyl phenyl phosphates with high ortho alkylation |
| 05/06/2009 | CN101426763A Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 05/06/2009 | CN101423624A Miniaturization organic phoshate nucleating agent and preparation method thereof |
| 05/06/2009 | CN101423534A Phosphorus-containing trifunctional liquid alicyclic epoxy resins and preparation method thereof |
| 05/06/2009 | CN101423533A Phosphorus-containing bifunctional liquid alicyclic epoxy resins and preparation method thereof |
| 05/06/2009 | CN101423532A Continuous crystallisation process in glyphosate production |
| 05/06/2009 | CN101423531A Method for preparing transparent concentrated soybean phospholipids by means of extraction |
| 05/06/2009 | CN101423530A Soya bean lecithin hydrogenization method using supercritical CO2 as dissolving agent |
| 05/06/2009 | CN101423481A Diketohydrazine derivative compound and medicine containing the compound as active ingredient |
| 05/06/2009 | CN100485016C Method for refining biologic diesel oil, phospholipid and glycerin by using leftovers of vegetable oil |
| 05/06/2009 | CN100484947C Cyclophosphaxene compound as photosensitivity flame-proof material and synthetic method thereof |
| 05/06/2009 | CN100484946C Cyclophosphaxene compound as flame-proof material and synthetic method thereof |
| 05/05/2009 | US7528280 Process for the preparation of biphosphonic acids |
| 05/05/2009 | US7528173 Plasma carboxypeptidase B inhibitors |
| 05/05/2009 | US7528121 Aurora kinases inhibitors; antiproliferative agents; specially for solid and haematological tumors; 2-[[3-({4-[(5-{2-[(3-fluorophenyl)amino]-2-oxoethyl}-1H-pyrazol-3-yl)amino]-quinazolin-7-yl}oxy)propyl](ethyl)amino]ethyl dihydrogen phosphate |
| 05/05/2009 | US7528120 phosphoric acid mono-[2-hydroxymethyl-4-(4-octyl-phenyl)-2-(1-oxo-1,3-dihydro-isoindol-2-yl)-butyl] ester; disorders mediated by lymphocytes interactions like transplant rejection, graft versus host disease, autoimmune diseases; binding affinity to Sphingosine-1-phosphate(S1P) receptors |
| 04/30/2009 | WO2009053445A2 Polymorphic forms of ibandronate sodium and processes for preparation thereof |
| 04/30/2009 | WO2009052993A1 Process for continuously preparing an organophosphorus compound and use thereof |
| 04/30/2009 | WO2006055879A3 Novel phosphorous containing steroid mimics |
| 04/30/2009 | US20090111998 Process for the preparation of carvedilol dihydrogen phosphate hemihydrate and pharmaceutical compositions thereof |
| 04/30/2009 | US20090111971 treating the unfolded protein with an oxycarbonyl-containing refolding agent selected from formic acid, acetic acid, propionic acid, lactic acid, tartaric acid, citric acid, succinic acid or polyether carboxylic acids and salts, to produce high purity proteins in high productivity |
| 04/30/2009 | US20090111802 Cyclocarbamate derivatives as progesterone receptor modulators |
| 04/30/2009 | US20090111774 Pmea lipid conjugates |
| 04/30/2009 | US20090111183 Ketone Ligands for Modulating the Expression of Exogenous Genes Via An Ecdysone Receptor Complex |
| 04/30/2009 | DE112006003798T5 Campherchinon-Derivat mit Acylphosphinoxid-Gruppe, Photopolymerisationskatalysator und Photo-/chemischer Polymerisationskatalysator sowie härtbare Zusammensetzung die dieses Derivat enthält Camphorquinone derivative containing with acyl phosphine oxide group, photopolymerization and Photo- / chemical polymerization catalyst and curable composition of this derivative |
| 04/29/2009 | EP2053394A2 Reagents and method for measuring hydroxyl number in polyols |
| 04/29/2009 | EP2053053A1 Method for continuous manufacture of an organophosphorus compound and its utilisation |
| 04/29/2009 | EP1786475B1 1,4-bis(carboxymethyl)-6-[bis(carboxymethyl)amino]-6-methyl-perhydro-1,4-diazepine (aazta) derivatives as ligands in high relaxivity contrast agents for use in magnetic resonance imaging (mri) |
| 04/29/2009 | EP1765812B1 Contrast agents endowed with high relaxivity for use in magnetic resonance imaging (mri) which contain a chelating moiety with polyhydroxylated substituents |
| 04/29/2009 | EP1423757B1 Bathochromic mono- and bis-acylphosphine oxides and sulfides and their use as photoinitiators |
| 04/29/2009 | EP1043327B1 Phosphonocephem derivatives, process for the preparation of the same, and use thereof |
| 04/29/2009 | CN101421285A Ferrocenediphosphines |
| 04/29/2009 | CN101421284A Crystalline forms of ibandronic acid and processes for preparation thereof |
| 04/29/2009 | CN101421283A Oligomeric and polymeric siloxanes substituted by arylphosphonic acids |
| 04/29/2009 | CN101418019A Novel production method of antioxidant 626 |
| 04/29/2009 | CN101418018A Method for preparing pentaerythritol bis-phosphite antioxidant |
| 04/29/2009 | CN101418017A Method for synthesizing (R)-9-(2-phosphate methoxy propyl)adenine |
| 04/29/2009 | CN101418016A Phosphorylation cephalosporin derivates |
| 04/29/2009 | CN101418015A Ceftriaxone phosphorylation derivates |
| 04/29/2009 | CN101418014A Method for preparing tetraphenyl phosphoric bromide |
| 04/29/2009 | CN101418013A Process for preparing intermediate ethyl methyl propionaldehyde phosphonate |
| 04/29/2009 | CN100483840C Organic electrolytic solution and lithium battery using the same |
| 04/29/2009 | CN100482671C Chiral monophosphorous ligand, synthetic method and its use |
| 04/29/2009 | CN100482344C Catalysts for nucleophilic substitution, synthesis thereof, compositions containing same and use thereof |
| 04/28/2009 | US7524991 Wittig-Horner reaction of a phosphonate or phosphonium compound to form carbanions; carbanions and 4-(N,N-diarylamino)benzaldehyde are subjected to condensation |
| 04/28/2009 | US7524981 Phospholipid derivatives and process for the production there |
| 04/28/2009 | US7524972 Synthetic molecules that specifically react with target sequences |
| 04/28/2009 | US7524969 Cardiovascular disorders; anticancer agents; antidiabetic agents; dietetics |
| 04/28/2009 | US7524951 Intermediates of 2-substituted carbapenem derivatives and process for production thereof |
| 04/28/2009 | US7524906 Process for the preparation of a metal-organic compound comprising at least one imine ligand |
| 04/28/2009 | US7524883 Eponemycin and epoxomicin analogs and uses thereof |
| 04/28/2009 | US7524832 Lyophile formulation of combretastatin A4 phosphate mono-tromethamine, wherein the pH is basified with sodium hydroxide or TRIS to prevent a pH drop during freezing; improved water solubility; rapidly regenerates combretastatin A-4 in vivo |
| 04/23/2009 | WO2009052050A1 Dioxolane thymine phosphoramidates as anti-hiv agents |
| 04/23/2009 | WO2009051392A2 Biocompatible suspension stabilizer for dispersing inorganic nanoparticles into aqueous solution |
| 04/23/2009 | WO2009051144A1 Process for production of dialkyl phosphate ester rare-earth salt or dioleyl phosphate ester rare-earth salt of |
| 04/23/2009 | WO2009051025A1 Catalyst for phosphorus-containing compound and sulfur-containing compound |
| 04/23/2009 | WO2009050731A2 Novel process for preparing risedronic acid |
| 04/23/2009 | WO2009050394A2 Use of cyclovinyl phosphine/copper complexes as arylation catalysts |
| 04/23/2009 | WO2009050372A2 Compositions containing lipophosphoramides and use thereof in gene therapy |
| 04/23/2009 | WO2009050284A2 Chiral tridentate compounds, corresponding organometal complexes, method for preparing same and use of said compounds and complexes as ligands in asymmetrical catalysis |
| 04/23/2009 | WO2009050042A1 Supported ionic liquids or activating supports |
| 04/23/2009 | WO2008131501A3 New anti-viral nucleoside analogs |
| 04/23/2009 | WO2008125911A8 Hydrogen splitting composition |
| 04/23/2009 | WO2008095069A3 High stability polyionic liquid salts |
| 04/23/2009 | WO2007011998A3 Diaryl alkylphosphonates and method for preparing same |
| 04/23/2009 | US20090105505 Process for the preparation of asymmetrically substituted biaryldiphosphines |
| 04/23/2009 | US20090105488 Triptycene derivatives and their application |
| 04/23/2009 | US20090105481 Asymmetric Catalytic Hydrogenation of Prochiral Ketones and Aldehydes |
| 04/23/2009 | US20090105452 Non-fluorescent quencher compounds and biomolecular assays |
| 04/23/2009 | US20090105432 Method for polymerising ethylenically unsaturated polyisobutene |